Anticancer agent 186

• UNSPSC Description:

  BET-IN-22 (compound 231) has anti-tumor effect[1].

• Target Antigen:

  Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  cancer

• Solubility:

  10 mM in DMSO

• Smiles:

  FC1(C2(CCN(C3=C(C(C4=C5NC=C4)=CN(C([2H])([2H])[2H])C5=O)C=C(C=C3)S(CC)(=O)=O)CC2)C1)F

• Molecular Weight:

  464.54

• References & Citations:

  [1]Hinova Pharmaceuticals Inc. Preparation of 1,6-dihydro-6-methyl-7H-pyrrolo[2,3-c]pyridin-7-one derivatives as BRD4 inhibitors. World Intellectual Property Organization, WO2020020308 A1 2020-01-30

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  9007-83-4